Panel backs lung cancer screening for some smokers

July 29, 2013 by Marilynn Marchione

Government advisers have endorsed lung cancer screening for the first time. They say certain current and former heavy smokers should get annual CT scans, a type of X-ray, to cut their chances of dying of the disease.

Monday's advice by the U.S. Preventive Services Task Force is a draft recommendation. If it becomes final as expected, it would clear the way for insurers to cover the scans. The panel recommends them for people ages 55 through 79 who smoked a pack of cigarettes a day for 30 years or the equivalent, such as two packs a day for 15 years.

Whether screening would help younger or lighter smokers is not known, so scans aren't advised for them. Scans also aren't advised for people who quit at least 15 years ago.

Explore further: Task force recommends new lung cancer screening guidelines

Related Stories

Task force recommends new lung cancer screening guidelines

June 21, 2012
A lung screening and surveillance task force, established by the American Association for Thoracic Surgery (AATS) and led by medical professionals from Brigham and Women's Hospital (BWH), is strongly recommending new guidelines ...

Lung cancer CT scans: Just for older heavy smokers

May 20, 2012
New lung cancer screening guidelines from three medical groups recommend annual scans but only for an older group of current or former heavy smokers.

Low-dose CT screening may benefit individuals at increased risk for lung cancer

May 20, 2012
Peter B. Bach, M.D., of the Memorial Sloan-Kettering Cancer Center, New York, and colleagues conducted a systematic review to examine the evidence regarding the benefits and harms of low-dose computerized tomography (LDCT) ...

Recommended for you

Discovery could lead to better results for patients undergoing radiation

July 19, 2017
More than half of cancer patients undergo radiotherapy, in which high doses of radiation are aimed at diseased tissue to kill cancer cells. But due to a phenomenon known as radiation-induced bystander effect (RIBE), in which ...

Definitive genomic study reveals alterations driving most medulloblastoma brain tumors

July 19, 2017
The most comprehensive analysis yet of medulloblastoma has identified genomic changes responsible for more than 75 percent of the brain tumors, including two new suspected cancer genes that were found exclusively in the least ...

Novel CRISPR-Cas9 screening enables discovery of new targets to aid cancer immunotherapy

July 19, 2017
A novel screening method developed by a team at Dana-Farber/Boston Children's Cancer and Blood Disorders Center—using CRISPR-Cas9 genome editing technology to test the function of thousands of tumor genes in mice—has ...

Combining CAR T cells with existing immunotherapies may overcome resistance in glioblastomas

July 19, 2017
Genetically modified "hunter" T cells successfully migrated to and penetrated a deadly type of brain tumor known as glioblastoma (GBM) in a clinical trial of the new therapy, but the cells triggered an immunosuppressive tumor ...

How CD44s gives brain cancer a survival advantage

July 19, 2017
Understanding the mechanisms that give cancer cells the ability to survive and grow opens the possibility of developing improved treatments to control or cure the disease. In the case of glioblastoma multiforme, the deadliest ...

New way found to boost immunity in fight cancer and infections

July 19, 2017
An international research team led by Université de Montréal medical professor Christopher Rudd, director of research in immunology and cell therapy at Maisonneuve-Rosemont Hospital Research Centre, has identified a key ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.